IQVIA’s Longitudinal Access and Adjudication Data (LAAD) enhanced with mortality data provides a comprehensive, patient-centric view by integrating prescription, medical claims, remittance, and the most complete U.S. mortality data, capturing 90% of deaths compared to CDC reporting. It enables insights into persistence, compliance, disease-specific mortality, and patient journeys from diagnosis to death. With customizable market definitions, 36 months of history, and flexible delivery, LAAD supports market access, commercial analytics, and treatment dynamics. Applications include payer impact analysis, adherence tracking, physician targeting, and reimbursement analytics.

Join for free to read